Roche
10:42 :
Swiss stocks rally, led by Novartis, Roche -
LONDON (MarketWatch) -- The Swiss stock market rallied on Thursday, boosted by solid gains for pharmaceutical firms. The SMI index rose 1.3% to 5,728. Shares in drug firm Roche Holding AG jumped 2.3%, while
Novartis AG was ...
04:25 :
Roche CEO Severin Schwan on Q3 outlook -
Oct. 13 - Severin Schwan, chief executive of Swiss pharma giant Roche talks to Reuters Insider, after posting a forecast dip in third-quarter sales figures.
02:39 :
Roche blames franc for 14 percent drop in sales -
GENEVA (AP) -- Swiss drug maker Roche Holding AG posted a 14 percent drop Thursday in year-on-year sales for the first nine months of 2011, blaming Switzerland's strong currency for weakening its results....
02:30 :
Strong Swiss franc hits Roche sales -
ZURICH (Reuters) - Roche kicked off the big pharma reporting season by posting slightly weaker-than-expected third-quarter sales, as the strong Swiss franc ate into the Swiss drugmaker's topline.
01:38 :
Roche sales off 13% in Swiss francs; confirms view -
MADRID (MarketWatch) -- Swiss drug group Roche Holding AG on Thursday reported sales totalled 31.49 billion Swiss francs ($35.1 billion) in the first nine months of the year, which was flat on constant exchange rates, but a 13% fall in Swiss ...
17:08 :
ASU licenses several biotech technologies to Roche -
Arizona State University will license several technologies to Basel, Switzerland-based Roche, the world’s largest biotech company. The technologies to develop a new DNA sequencing system were developed by Dr. Stuart Lindsay at the Biodesign ...
07:22 :
Drugs Withheld From Greek Hospitals -
Roche quit delivering drugs to some state-funded hospitals in
Greece that haven't paid back bills and may take similar steps elsewhere in a sign of how the debt crisis is affecting consumers and companies.
19:00 :
Roche Keeps Drugs From Greek Hospitals -
Roche quit delivering drugs to some state-funded hospitals in
Greece that haven't paid back bills and may take similar steps elsewhere in a sign of how the debt crisis is affecting consumers and companies.
08:28 :
Advanced Explorations Inc. Progressing With Feasibility Study -
TORONTO, ONTARIO--(Marketwire - Sept. 7, 2011) - Advanced Explorations Inc. (the "Company" or "AEI") (TSX VENTURE:AXI)(FRANKFURT:AE6) is pleased to announce that work continues in support of the Roche Bay Feasibility Study ("FS"). In addition ...
09:18 :
Roche Cancer Drug Is Approved -
The FDA granted early approval to Roche's targeted melanoma drug, part of an emerging class of treatments that target the molecular underpinnings of cancer.
10:28 :
Roche climbs 3% in wake of Tarceva vote -
BOSTON (MarketWatch) -- Shares of Swiss pharmaceutical juggernaut Roche climbed 3% in early trading Monday, making it the top gainer among the major pharmaceutical issues. On Friday, a European advisory panel voted for the expanded use of ...
03:26 :
Roche's Profit Drops 6% -
Roche Holding reported better-than-expected first-half results and lifted its outlook for the full year as the company's restructuring helped the Swiss pharma giant contain the negative effect from the strong franc and sliding sales of cancer ...
01:51 :
Roche lifts outlook as profit slips 6% -
LONDON (MarketWatch) -- Swiss drug maker Roche Holding AG on Thursday lifted its outlook for the year as it reported a 5.8% drop in first-half profit that still comfortably beat market expectations. Roche said profit for the period ...
actualidad Roche -